The Michigan-based company, nanoRETE, specializes in developing portable biosensors using nanoparticles for rapid diagnosis of infectious diseases. Their handheld point-of-care devices are used in various sectors such as public health, homeland defense, and the food supply chain. By utilizing customized, proprietary nano-particle biosensors, nanoRETE's diagnostic platform offers real-time detection of pathogens and toxins. Their innovative technology aims to replace sub-optimal tuberculosis screening tests, providing a superior diagnostic tool that advances the market to a single point of care, benefiting multiple economic infrastructural sectors. Founded in 2011, nanoRETE is revolutionizing the field of biosensing for improved disease detection and prevention.